Table 1.
HSV isolates assessed in this studya
Isolate | Type | Gender/age (yr) | Anatomical location of lesion | EC50 of acyclovir | EC50 of foscarnet |
---|---|---|---|---|---|
Acyclovir-sensitive HSV | |||||
HSV-1 | 1 | M/22 | Orolabial | 1.6 μMb | NDc |
HSV-2 | 2 | F/24 | Genital | 1.6 μMb | ND |
Acyclovir-resistant HSV | |||||
DE-5016 | 1 | M/61 | Corneal | >80 μM | 80 μM |
DE-625 | 2 | M/60 | Knee pit | >80 μM | ND |
DE-3657 | 2 | F/52 | Genital | >80 μM | 30 μM |
DE-6820 | 2 | F/83 | Genital | 80 μM | 50 μM |
DE-14574 | 2 | F/82 | Genital | >80 μM | 125 μM |
The acyclovir-resistant isolates were analyzed with a plaque assay at Sahlgrenska University Hospital, Gothenburg, Sweden. The reference values for acyclovir and foscarnet resistance were >4 μM and >160 μM, respectively.
EC50s as presented in Fig. 3, analyzed by qPCR.
ND, not determined.